Skip to Content
  • Previous Rank
    250
  • Revenues ($M)
    24,890
  • Revenue Percent Change
    122.2%
  • Profits ($M)
    12,101
  • Profits Percent Change
    293.6%
  • Market Value (as of March 31, 2015)
    145,533

The biopharmaceutical company develops medications that are used to treat patients with HIV/AIDS, hepatitis, and cardiovascular disease, among others.

Company Info

CEO
John F. Milligan
Industry
Pharmaceuticals
Sector
Health Care
HQ Location
Foster City, CA
Websitehttp://www.gilead.com
Years on List7
Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)24,890122.2%
Profits ($M)12,101293.6%
Total Stockholder Equity15,426-
Employees7,000-
Market Value (as of March 31, 2015)145,533-

Profit Ratios

Profit as % of Revenues48.6%
Profits as % of Assets34.9%
Profits as % of Stockholder Equity78.4%

Earnings Per Share (last fiscal year)

Earnings Per Share ($)7.35
EPS % Change (from 2013)306.1%
EPS % Change (5 year annual rate)39.1%
EPS % Change (10 year annual rate)40.4%

Total Return

Total Return to Investors (2014)25.5%
Total Return to Investors (5 year, annualized)34.2%
Total Return to Investors (10 year, annualized)26.8%